Risk of malignant lymphoma in patients with previous tuberculosis infection: a cohort study.

Ann Hematol

Division of Hematology & Medical Oncology, Department of Internal Medicine, Hanyang University Medical Centre, Hanyang University College of Medicine, Seoul, Republic of Korea.

Published: January 2025

Tuberculosis (TB) is associated with chronic inflammation, which has been implicated in the pathogenesis of various malignancies, including lung cancer. However, the relationship between TB and hematological malignancies like lymphoma remains less understood. This study aimed to investigate risks of incident malignant lymphoma according to previous TB infection in a large prospective cohort of 347,204 individuals. Multiple logistic regression analyses were conducted to predict the probability of malignant lymphoma. Propensity score matching was employed to compare the incidence of lymphoma in individuals with and without previous TB infection. Among the overall population, 3.7% (12,694) reported previous history of TB. There was a significantly increased risk of lymphoma in individuals with a TB history, with an odds ratio of 2.14 (95% confidence interval (CI): 1.35-3.39, p = 0.001) and a hazard ratio of 2.13 (95% CI, 1.13-4.00; p = 0.019) in propensity-matched analyses. These findings underscore TB infection as a potential precursor to lymphoma, probably due to prolonged inflammatory and immune dysregulation. The study highlights the importance of considering a TB history in the risk assessment for lymphoma, emphasizing the need for vigilant clinical monitoring in population with high TB burden.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-024-06159-zDOI Listing

Publication Analysis

Top Keywords

malignant lymphoma
12
lymphoma
8
previous infection
8
lymphoma individuals
8
risk malignant
4
lymphoma patients
4
previous
4
patients previous
4
previous tuberculosis
4
infection
4

Similar Publications

ITK-SYK and TEL-SYK (also known as ETV6-SYK) are human tumor-causing chimeric proteins containing the kinase region of SYK, and the membrane-targeting, N-terminal, PH-TH domain-doublet of ITK or the dimerizing SAM-PNT domain of TEL, respectively. ITK-SYK causes peripheral T cell lymphoma, while TEL-SYK was reported in myelodysplastic syndrome. BTK is a kinase highly related to ITK and to further delineate the role of the N-terminus, we generated the corresponding fusion-kinase BTK-SYK.

View Article and Find Full Text PDF

Obstructive shock secondary to an unusual cause: primary cardiac lymphoma.

J Cardiothorac Surg

January 2025

Réanimation Médicale et Chirurgicale, CHU de Guadeloupe, Les Abymes, Guadeloupe, 97139, France.

Background: The medico-surgical management of cardiac tumors when there is a suspicion of malignancy is complex. Moreover, in a critically ill setting, the choice of diagnostic tools seems crucial.

Case Presentation: We present the case of a sixty-four-year-old patient with no prior medical history who was admitted to the intensive care unit with obstructive shock secondary to a right heart mass and pulmonary embolism.

View Article and Find Full Text PDF

Overall and late mortality among 24 459 survivors of adolescent and young adult cancer in Alberta, Canada: a population-based cohort study.

Lancet Public Health

January 2025

Department of Oncology, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Arthur Child Comprehensive Cancer Centre, Calgary, AB, Canada. Electronic address:

Background: Adolescent and young adult (AYA) cancer survivors are at an increased risk of premature mortality due to their cancer and its treatment. Herein, we aimed to quantify the excess risks of mortality among AYA cancer survivors and identify target populations for intervention.

Methods: The Alberta AYA Cancer Survivor Study is a retrospective, population-based cohort of individuals diagnosed with a first primary neoplasm at age 15-39 years in Alberta, Canada, between 1983 and 2017.

View Article and Find Full Text PDF

Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer.

Cancer Lett

January 2025

Clinical and Health Sciences, University of South Australia, Adelaide, Australia; Department of Histopathology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland. Electronic address:

Metabolic reprogramming is a hallmark of cancer, crucial for malignant transformation and metastasis. Chronic lymphocytic leukaemia (CLL) and prostate cancer exhibit similar metabolic adaptations, particularly in glucose and lipid metabolism. Understanding this metabolic plasticity is crucial for identifying mechanisms contributing to metastasis.

View Article and Find Full Text PDF

Clinical Management of Human Herpesvirus-8 related illnesses in solid organ transplant recipients.

J Infect

January 2025

Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK; Centre for Immunology and Vaccinology, Department of Infectious Diseases, Imperial College, London, UK. Electronic address:

In solid organ transplant recipients (SOTRs), the oncogenic virus human herpesvirus-8 (HHV-8) also named Kaposi sarcoma herpesvirus (KSHV) causes four clinical diseases: Kaposi Sarcoma, Primary Effusion Lymphoma, Multicentric Castleman Disease (MCD), and KSHV inflammatory cytokine syndrome (KICS). This review outlines these clinical scenarios and discusses their management. Although HHV8 related disease in SOTR was first described more than three decades ago, there is a lack of data on treatment so much of the guidance is based on evidence in other immunodeficient patients, particularly people living with HIV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!